SYN Synthetic Biologics Inc

Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.

$0.70
As of 02/23/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
06/26/2007
19,993,390
19,835,104
$14,079,345
0.00%
SEC Edgar Online
10-Q
10-K
87164U201
US87164U2015
BG4SNW4

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
117.37
0.00
183.01%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy